• 11780 Citations
  • 38 h-Index
1973 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where I. Láng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
letrozole Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Antibody-Dependent Cell Cytotoxicity Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Silymarin Medicine & Life Sciences
Antibodies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

  • 11780 Citations
  • 38 h-Index
  • 218 Article
  • 2 Chapter
  • 1 Editorial
12 Citations (Scopus)

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Láng, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno-Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & de Azambuja, E., jan. 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 86-94 9 p.

Research output: Article

Amenorrhea
Breast Neoplasms
Survival
Hormones
Therapeutics

Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

Huober, J., Holmes, E., Baselga, J., de Azambuja, E., Untch, M., Fumagalli, D., Sarp, S., Láng, I., Smith, I., Boyle, F., Xu, B., Lecocq, C., Wildiers, H., Jouannaud, C., Hackman, J., Dasappa, L., Ciruelos, E., Toral Pena, J. C., Adamchuk, H., Hickish, T. & 5 others, de la Pena, L., Jackisch, C., Gelber, R. D., Piccart-Gebhart, M. & Di Cosimo, S., szept. 1 2019, In : European Journal of Cancer. 118, p. 169-177 9 p.

Research output: Article

Phase III Clinical Trials
Disease-Free Survival
Outcome Assessment (Health Care)
Breast Neoplasms
Survival
21 Citations (Scopus)

Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: Final analysis of the CALOR trial

Wapnir, I. L., Price, K. N., Anderson, S. J., Robidoux, A., Martín, M., Nortier, J. W. R., Paterson, A. H. G., Rimawi, M. F., Láng, I., Baena-Cañada, J. M., Thürlimann, B., Mamounas, E. P., Geyer, C. E., Gelber, S., Coates, A. S., Gelber, R. D., Rastogi, P., Regan, M. M., Wolmark, N. & Aebi, S., ápr. 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1073-1079 7 p.

Research output: Article

Estrogen Receptors
Breast Neoplasms
Recurrence
Drug Therapy
Disease-Free Survival